3 Penny Stocks That Investors Are Adding to Their Watchlists Next Month
With the year coming to an end for trading penny stocks and blue chips, there are a lot of factors for investors to consider. While 2021 was in no way a banner year for stability, 2022 could have a lot of potential for penny stocks.
To understand this, we have to take a look at what we have to look forward to this coming year. For one, many believe that the pandemic could begin to come to an end. With cases surging right now due to the Omicron variant, investors are excited at the idea that Covid could become endemic in the near future. In addition, we are seeing the S&P 500 continue to hit record highs amidst all of this volatility.
So, with all of this going on, investing in penny stocks is not the easiest right now. But, there is a lot of potential with the market moving into 2022. As always, it’s crucial to stay ahead of the game and understand exactly what’s going on in the market and how to take advantage. With all of that in mind, let’s take a look at three penny stocks to watch in January 2022.
3 Penny Stocks to Watch in January 2022
- Ambev ADR (NYSE: ABEV)
- Asensus Surgical Inc. (NYSE: ASXC)
- AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX)
Ambev ADR (NYSE: ABEV)
Up by around 1.2% by EOD on December 31st are shares of ABEV stock. With a YTD drop of around 8.5%, ABEV stock’s performance is nothing to write home about. However, the company has been making some headway in the past few weeks. If you’re not familiar, Ambev is a Brazilian producer of a long list of popular beverage brands. In its latest Q3, the company posted exciting results.
During the third quarter, Ambev reported a quarterly net profit of over 57% higher than the previous years same quarter. Additionally, the company posted a 20% annual rise in net revenue with an adjusted EBITDA growth of 7.8%. Now, there are a few things to consider when looking at Ambev. For one, the sale of alcohol and other beverages, tends to rise during times of both economic turmoil and prosperity.
As a result, we’ve seen shares of ABEV continue to be highly volatile over the past few months. Next, with this massive growth in its financials, the company has received a sizable amount of attention as of recently. So, while it is hard to say where Ambev ADR is headed, we do know that the company is continuing to push its long-term growth strategy. Considering this, will it be on your list of penny stocks to watch?
Asensus Surgical Inc. (NYSE: ASXC)
Another decent gainer of the day so far is Asensus Surgical Inc. Up 3.2% on December 31st, shares of ASXC stock have shot up by a sizable 75% over the past twelve-month period. Because of this, many investors are focused on the company right now. Its most recent update came a few days ago when the company announced its participation in the annual J.P. Morgan Healthcare Conference as well as the H.C. Wainwright Bioconnect 2022 Conference.
If you’re not familiar with Asensus, it is a biotech penny stock working to digitize the interface between surgeons and patients. The company’s technology lies in the field of performance-guided surgery which includes products such as the Senhance Surgical System powered by its Intelligent Surgical Unit or ISU. These machines can vastly improve clinical outcomes and offer a new range of value-based healthcare for patients and doctors alike. And as a result, the company is a cutting-edge player in the biotech industry.
Last month, it announced the purchase of a Senhance Surgical System by the Private Healthcare Instutiton Railway Clinical Hospital RZD Medicine of Rostov-on-Don. This is one of a handful of recent purchases of the company’s technology. Whether this makes ASXC stock worth buying or not, however, is up to you.
AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX)
One of the bigger gainers of the day during trading on New Years Eve is ACRX stock. By EOD, shares of the biotech penny stock had shot up by over 12% to $0.55. While ACRX stock is still down by around 55% for the year, this small bullish turnaround is good news for the company. Only a few weeks ago, AcelRx announced the publication of data for those undergoing total hip and knee replacement utilizing sublingual sufentanil as opposed to traditional opioid drugs.
“While Dr. Wiesner and his colleagues practice state-of-the-art multimodal analgesia in their total joint program, by using SST they were able to even further reduce their reliance on IV opioids in the perioperative setting. Real-world studies continue to show that SST is well tolerated by the older patient population that generally undergoes these total joint procedures.”The CMO of AcelRx, Dr. Pamela Palmer
This is great news for the company and could help the longer-term use case for its Dsuvia product. Aside from this, AcelRx is working on several other product candidates. This includes its Zalviso product and more. So, if we consider all of this, does ACRX stock look like it is worth adding to your watchlist next year?
Which Penny Stocks Are You Watching Right Now?
If you’re making a list of the best penny stocks to buy, there are hundreds of options to choose from. But, because of the sheer number of penny stocks out there, it can be difficult to pick the best ones to buy. However, because of the large breadth of options, the opportunity to make money with penny stocks is palpable.
As prudent investors, we always need to stay on our toes to see what is going on in the stock market and how to benefit. With the pandemic continuing to wreak havoc on volatility, knowing how to benefit from world events will be a major asset. With that in mind, which penny stocks are you watching right now?
If you enjoyed this article and you’re interested in learning how to trade so you can have the best chance to profit consistently then you need to checkout this YouTube channel. CLICK HERE RIGHT NOW!